These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 1568829)

  • 1. [Pharmacokinetics in Gilbert-Meulengracht disease].
    Poralla T
    Internist (Berl); 1992 Feb; 33(2):122-3. PubMed ID: 1568829
    [No Abstract]   [Full Text] [Related]  

  • 2. [Meulengracht disease].
    Zeitz J; Schmidinger I; Rentsch K; Rogler G; Vavricka S
    Praxis (Bern 1994); 2013 Jan; 102(3):129-35. PubMed ID: 23384981
    [No Abstract]   [Full Text] [Related]  

  • 3. UDPglucuronosyltransferase deficiency in man and animals.
    Roy Chowdhury J; Roy Chowdhury N; Arias IM
    Biochem Soc Trans; 1984 Feb; 12(1):81-3. PubMed ID: 6423423
    [No Abstract]   [Full Text] [Related]  

  • 4. Genetic lesions of bilirubin uridine-diphosphoglucuronate glucuronosyltransferase (UGT1A1) causing Crigler-Najjar and Gilbert syndromes: correlation of genotype to phenotype.
    Kadakol A; Ghosh SS; Sappal BS; Sharma G; Chowdhury JR; Chowdhury NR
    Hum Mutat; 2000 Oct; 16(4):297-306. PubMed ID: 11013440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Genetic polymorphism in Gilbert-Meulengracht syndrome (GMS)].
    Fengler JD; Baumgarten R; Eike E; Eike O; Siegmund W; Franke G; Zschiesche M
    Z Gastroenterol; 1993 Feb; 31 Suppl 2():81-2. PubMed ID: 7483725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of in-vivo and in-vitro drug metabolism in patients with Gilbert's syndrome.
    Narang AP; Datta DV
    J Assoc Physicians India; 1982 Jun; 30(6):357-9. PubMed ID: 6763035
    [No Abstract]   [Full Text] [Related]  

  • 7. [Unconjugated hyperbilirubinemia. Diagnostic orientation].
    Girot R
    Rev Prat; 1991 Sep; 41(19):1837-41. PubMed ID: 1925365
    [No Abstract]   [Full Text] [Related]  

  • 8. Neonatal hyperbilirubinemia and a common mutation of the bilirubin uridine diphosphate-glucuronosyltransferase gene in Japanese.
    Akaba K; Kimura T; Sasaki A; Tanabe S; Wakabayashi T; Hiroi M; Yasumura S; Maki K; Aikawa S; Hayasaka K
    J Hum Genet; 1999; 44(1):22-5. PubMed ID: 9929972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Not Available].
    Vavricka S
    Praxis (Bern 1994); 2013 Mar; 102(6):315-6. PubMed ID: 23547323
    [No Abstract]   [Full Text] [Related]  

  • 10. [Not Available].
    Aeschlimann AG
    Praxis (Bern 1994); 2013 Mar; 102(6):315. PubMed ID: 23485750
    [No Abstract]   [Full Text] [Related]  

  • 11. Gilbert's syndrome--clinical and pharmacological implications.
    Radu P; Atsmon J
    Isr Med Assoc J; 2001 Aug; 3(8):593-8. PubMed ID: 11519385
    [No Abstract]   [Full Text] [Related]  

  • 12. [Gilbert-Meulengracht disease].
    Haugen OH
    Tidsskr Nor Laegeforen; 1985 May; 105(13):882-4. PubMed ID: 4012693
    [No Abstract]   [Full Text] [Related]  

  • 13. [Does hyperbilirubinemia in Meulengracht disease (Gilbert syndrome) need treatment?].
    Beckh K
    Internist (Berl); 1994 Nov; 35(11):1075. PubMed ID: 7822130
    [No Abstract]   [Full Text] [Related]  

  • 14. [Causes of hyperbilirubinemia in newborns and infants].
    Iwańczak F; Prandota J; Iwańczak B
    Pediatr Pol; 1980 May; 55(5):61-8. PubMed ID: 6773020
    [No Abstract]   [Full Text] [Related]  

  • 15. [The Gilbert-Meulengracht syndrome--diagnosis and management in the physician's practice].
    Fengler JD; Markus R; Spallek E; Eike O; Baumgarten R
    Z Arztl Fortbild (Jena); 1989; 83(6):283-6. PubMed ID: 2735075
    [No Abstract]   [Full Text] [Related]  

  • 16. TATA-box mutant in the promoter of the uridine diphosphate glucuronosyltransferase gene in Italian patients with Gilbert's syndrome.
    Sampietro M; Lupica L; Perrero L; Romano R; Molteni V; Fiorelli G
    Ital J Gastroenterol Hepatol; 1998 Apr; 30(2):194-8. PubMed ID: 9675658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hyperbilirubinemia in liver diseases].
    Stiehl A
    Fortschr Med; 1982 May; 100(18):842-5. PubMed ID: 6807787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-specific drug-metabolizing enzyme activity in Gilbert disease.
    Várkonyi A; Szeleczki T; Csanádi J; Gyurkovits K
    Acta Med Hung; 1984; 41(4):239-46. PubMed ID: 6440117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug prescribing in children with renal failure.
    Moudgil A; Srivastava RN
    Indian Pediatr; 1989 Jul; 26(7):693-705. PubMed ID: 2684862
    [No Abstract]   [Full Text] [Related]  

  • 20. [Elimination of drugs. Elimination half-life of a drug].
    Della Negra M; Woronoff-Lemsi MC
    Soins; 1998; (627):57-8. PubMed ID: 9783022
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.